Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1971 Oct;43(2):379–388.

Mechanism of potentiation of contractor responses to catecholamines by methylxanthines in aortic strips

S Kalsner
PMCID: PMC1665836  PMID: 5158204

Abstract

1. Caffeine and theophylline increased the amplitude of contractor esponses of untreated and reserpine pretreated rabbit aortic strips to catecholamines (adrenaline, α-methylnoradrenaline, noradrenaline). Responses to amines without both the 3- and 4-OH groups in the benzene ring (methoxamine, phenylephrine, Synephrine) were not increased by theophylline and only those to Synephrine were slightly enhanced by caffeine.

2. Compounds which inhibit catechol-O-methyltransferase (pyrogallol, tropolone, U-0521) potentiated responses to catecholamines and abolished the enhancing effect of theophylline and caffeine. Also, the potentiation produced by inhibitors of O-methylation was significantly reduced in the presence of the methylxanthines.

3. Experiments done with the aid of the technique of oil immersion, to eliminate the diffusion of drug from the tissue into the bathing medium, showed that theophylline and caffeine decreased the rate of inactivation of adrenaline by O-methylation.

4. These findings indicate that methylxanthines potentiate the contractor responses to catecholamines in aortic strips by inhibiting their extraneuronal inactivation.

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BELLEAU B., BURBA J. Tropolones: a unique class of potent non-competitive inhibitors of S-adenosylmethionine-catechol methyltransferase. Biochim Biophys Acta. 1961 Nov 25;54:195–196. doi: 10.1016/0006-3002(61)90956-8. [DOI] [PubMed] [Google Scholar]
  2. BUTCHER R. W., SUTHERLAND E. W. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962 Apr;237:1244–1250. [PubMed] [Google Scholar]
  3. Bartelstone H. J., Nasmyth P. A., Telford J. M. The significance of adenosine cyclic 3',5'-monophosphate for the contraction of smooth muscle. J Physiol. 1967 Jan;188(2):159–176. doi: 10.1113/jphysiol.1967.sp008131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beavo J. A., Rogers N. L., Crofford O. B., Hardman J. G., Sutherland E. W., Newman E. V. Effects of xanthine derivatives on lipolysis and on adenosine 3',5'-monophosphate phosphodiesterase activity. Mol Pharmacol. 1970 Nov;6(6):597–603. [PubMed] [Google Scholar]
  5. FURCHGOTT R. F. The pharmacology of vascular smooth muscle. Pharmacol Rev. 1955 Jun;7(2):183–265. [PubMed] [Google Scholar]
  6. Giles R. E., Miller J. W. The catechol-O-methyl transferase activity and endogenous catecholamine content of various tissues in the rat and the effect of administration of U-0521 (3',4'-dihydroxy-2-methyl propiophenone). J Pharmacol Exp Ther. 1967 Nov;158(2):189–194. [PubMed] [Google Scholar]
  7. Goldman J. M., Hadley M. E. Cyclic AMP and adrenergic receptors in melanophore responses to methylxanthines. Eur J Pharmacol. 1970;12(3):365–370. doi: 10.1016/0014-2999(70)90089-0. [DOI] [PubMed] [Google Scholar]
  8. Kalsner S. Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta. Circ Res. 1969 Mar;24(3):383–395. doi: 10.1161/01.res.24.3.383. [DOI] [PubMed] [Google Scholar]
  9. Kalsner S., Nickerson M. A method for the study of mechanisms of drug disposition in smooth muscle. Can J Physiol Pharmacol. 1968 Sep;46(5):719–730. doi: 10.1139/y68-113. [DOI] [PubMed] [Google Scholar]
  10. Kalsner S., Nickerson M. Disposition of norepinephrine and epinephrine in vascular tissue, determined by the technique of oil immersion. J Pharmacol Exp Ther. 1969 Feb;165(2):152–165. [PubMed] [Google Scholar]
  11. Kalsner S., Nickerson M. Disposition of phenylephrine in vascular tissue, determined by the oil-immersion technique. J Pharmacol Exp Ther. 1968 Sep;163(1):1–10. [PubMed] [Google Scholar]
  12. Kalsner S., Nickerson M. Effects of a haloalkylamine on responses to and disposition of sympathomimetic amines. Br J Pharmacol. 1969 Mar;35(3):440–455. doi: 10.1111/j.1476-5381.1969.tb08285.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kalsner S., Nickerson M. Mechanism of cocaine potentiation of responses to amines. Br J Pharmacol. 1969 Mar;35(3):428–439. doi: 10.1111/j.1476-5381.1969.tb08284.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kalsner S. Steroid potentiation of responses to sympathomimetic amines in aortic strips. Br J Pharmacol. 1969 Jul;36(3):582–593. doi: 10.1111/j.1476-5381.1969.tb08013.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Klaus W., Krebs R., Seitz N. Uber die Dissoziation von Funktion und Stoffwechsel des isolierten Meerschweinchenherzens unter dem Einfluss von Phosphodiesterase-Hemmstoffen. Naunyn Schmiedebergs Arch Pharmakol. 1970;267(2):99–113. [PubMed] [Google Scholar]
  16. Levy B., Wilkenfeld B. E. The potentiation of rat uterine inhibitory responses to noradrenaline by theophylline and nitroglycerine. Br J Pharmacol. 1968 Nov;34(3):604–612. doi: 10.1111/j.1476-5381.1968.tb08489.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. MAVRIDES C., MISSALA K., D'IORIO A. The effect of 4-methyltropolone on the metabolism of adrenaline. Can J Biochem Physiol. 1963 Jul;41:1581–1587. [PubMed] [Google Scholar]
  18. Schonhofer P. S., Skidmore I. F., Forn J., Fleisch J. H. Adenyl cyclase activity of rabbit aorta. J Pharm Pharmacol. 1971 Jan;23(1):28–31. doi: 10.1111/j.2042-7158.1971.tb12776.x. [DOI] [PubMed] [Google Scholar]
  19. Turtle J. R., Kipnis D. M. An adrenergic receptor mechanism for the control of cyclic 3'5' adenosine monophosphate synthesis in tissues. Biochem Biophys Res Commun. 1967 Sep 7;28(5):797–802. doi: 10.1016/0006-291x(67)90388-9. [DOI] [PubMed] [Google Scholar]
  20. ZELLER E. A., BARSKY J. In vivo inhibition of liver and brain monoamine oxidase by 1-Isonicotinyl-2-isopropyl hydrazine. Proc Soc Exp Biol Med. 1952 Nov;81(2):459–461. doi: 10.3181/00379727-81-19910. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES